华夏恒生生物科技ETF发起式联接(QDII)C(016971)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
786,852.01 |
647,032.00 |
181,136.63 |
1,125,853.57 |
存出保证金 |
310,733.22 |
164,780.58 |
166,503.73 |
84,585.56 |
交易性金融资产 |
1,120,020,478.13 |
568,246,350.94 |
377,923,357.93 |
455,183,785.86 |
其中:股票投资 |
- |
7,600,225.15 |
- |
4,189,535.72 |
债券投资 |
30,164,706.85 |
- |
509,095.21 |
2,137,642.38 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
4,107,012.21 |
- |
- |
3,362,465.49 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
33,993,391.68 |
6,695,125.72 |
5,229,717.44 |
7,546,504.71 |
其他资产 |
- |
- |
- |
- |
资产总计 |
1,212,723,229.04 |
613,167,400.69 |
405,296,493.35 |
493,753,839.08 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
1,374,152.16 |
3,493,209.84 |
0.91 |
应付赎回款 |
65,292,861.84 |
10,249,672.41 |
3,821,364.12 |
14,858,478.69 |
应付管理人报酬 |
20,006.22 |
17,244.38 |
8,538.13 |
11,473.78 |
应付托管费 |
6,001.89 |
5,173.31 |
2,561.44 |
3,442.12 |
应付销售服务费 |
180,687.30 |
118,169.71 |
77,782.72 |
89,824.82 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
334,715.82 |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
81,822.86 |
157,023.57 |
84,535.36 |
30,008.10 |
负债合计 |
65,916,095.93 |
11,921,435.54 |
7,487,991.61 |
14,993,228.42 |
所有者权益 |
实收基金 |
1,071,286,582.63 |
835,013,299.86 |
643,837,556.40 |
573,577,948.51 |
未分配利润 |
75,520,550.48 |
-233,767,334.71 |
-246,029,054.66 |
-94,817,337.85 |
所有者权益合计 |
1,146,807,133.11 |
601,245,965.15 |
397,808,501.74 |
478,760,610.66 |
负债及所有者权益总计 |
1,212,723,229.04 |
613,167,400.69 |
405,296,493.35 |
493,753,839.08 |